Tutorials
TherapeuticsMD Inc logo

TherapeuticsMD Inc

$ 8.86 -0.38 (-4.11%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 83.06M
Enterprise V:
$ 268.37M
Volume:
106.50K
Avg Vol (2M):
1.07M
Also Trade In:
Volume:
106.50K
Market Cap $:
83.06M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.07M
Enterprise Value $:
268.37M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

TherapeuticsMD Inc
NAICS : 325412 SIC : 2834
951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
Description
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 0.14
Equity-to-Asset -1.05
Debt-to-Equity -1.51
Debt-to-EBITDA -1.35
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.34
Distress
Grey
Safe
Beneish M-Score -3.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.94
9-Day RSI 61.41
14-Day RSI 57.64
6-1 Month Momentum % -31.08
12-1 Month Momentum % -80.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.32
Quick Ratio 0.28
Cash Ratio 0.11
Days Inventory 149.26
Days Sales Outstanding 148.83
Days Payable 328.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.4

Financials (Next Earnings Date:2022-08-15)

TXMD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TXMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 86.418
EPS (TTM) ($) -21.691
Beta 1.53
Volatility % 93.98
14-Day RSI 57.64
14-Day ATR ($) 0.977412
20-Day SMA ($) 6.865
12-1 Month Momentum % -80.09
52-Week Range ($) 1.99 - 47.95
Shares Outstanding (Mil) 9.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TherapeuticsMD Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More